Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Chronic Achilles Tendon Pain
NCT06100822Phase 1Terminated
- Start
- May 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) in Achilles tendinopathy (2 arms). Primary endpoint: Victorian Institute of Sport Assessment - Achilles Score at 16 weeks. Started May 2024; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Achilles tendinopathy
Beyond the preview
Go deeper on NCT06100822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06100822.